Apoptosis induction in peripheral leukemia cells by remission induction treatment in vivo: selective depletion and apoptosis in a CD34+ subpopulation of leukemia cells
- 18 September 2003
- journal article
- clinical trial
- Published by Springer Nature in Leukemia
- Vol. 17 (11) , 2130-2139
Abstract
In vitro studies demonstrating the induction of programmed cell death by cytotoxic drugs used in anticancer chemotherapy suggested that antileukemic treatment eliminates leukemia cells by apoptosis. We therefore analyzed apoptosis induction and activation of apoptosis signaling molecules in patients receiving remission induction treatment for AML and ALL during the initial phase of leukemia cell reduction. A coexistence of distinct populations of CD34+ and CD34− leukemia cells could be identified. During chemotherapy, CD34+ leukemia cells were more rapidly depleted than CD34− cells. Furthermore, a significant increase in leukemia cell apoptosis ex vivo was detected in CD34+ cells, while no such increase was observed in the CD34− subpopulation, suggesting that CD34+ leukemia cells are the main targets for apoptosis induction through antileukemic treatment. No alterations in Bax and Bcl-2 expression were found during in vivo chemotherapy, and CD95 expression and sensitivity remained low, indicating the induction of apoptosis independent of the CD95 system or regulation of protein levels of Bax and Bcl-2. The data suggest that analysis of leukemia cell subpopulations is required for further identification of apoptosis signaling molecules relevant for response to treatment and assessment of drug efficacy in vivo and in vitro.Keywords
This publication has 40 references indexed in Scilit:
- Diversity of the apoptotic response to chemotherapy in childhood leukemiaLeukemia, 2002
- Activation of apoptosis pathways in peripheral blood lymphocytes by in vivo chemotherapyBlood, 2001
- High bax expression is a good prognostic indicator in acute myeloid leukaemiaBritish Journal of Haematology, 2000
- Expression of Apoptosis-Controlling Proteins in Acute Leukemia CellsLeukemia & Lymphoma, 1999
- High expression of bcl-2 mRNA as a determinant of poor prognosis in acute myeloid leukemiaAnnals of Oncology, 1998
- BCL-2 Expression and Prognosis in Childhood Acute LeukemiaPediatric Hematology and Oncology, 1998
- Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cellNature Medicine, 1997
- Expression of Fas antigen in acute myeloid leukaemia is associated with therapeutic response to chemotherapyBritish Journal of Haematology, 1996
- Involvement of the CD95 (APO–1/Fas) receptor/ligand system in drug–induced apoptosis in leukemia cellsNature Medicine, 1996
- Induction of apoptosis in childhood acute leukemia by chemotherapeutic agents: Failure to detect evidence of apoptosis in vivoEuropean Journal of Haematology, 1994